Morphine and alternative opioids in cancer pain: the EAPC recommendations

References

Page 1

	Year	Citations
Breakthrough pain: definition, prevalence and characteristics Russell K. Portenoy, Neil A. Hagen Pain	1990	916
Epidural clonidine analgesia for intractable cancer pain James C. Eisenach, Stuart DuPen, Michel Y. Dubois, Pain Pain TherapySurgical OncologyPain MedicineMorphine UsePharmacotherapy	1995	537
Opioid rotation for toxicity reduction in terminal cancer patients Noe ́mi D. de Stoutz, Eduardo Bruera, María E. Suarez‐Almazor Journal of Pain and Symptom Management	1995	385
Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? Carla Ripamonti, L Groff, Cinzia Brunelli, Journal of Clinical Oncology	1998	341
Morphine and oxycodone hydrochloride in the management of cancer pain Eija Kalso, Anneli Vainio Clinical Pharmacology & Therapeutics	1990	260
Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study Russell K. Portenoy, Richard Payne, Paul Coluzzi, Pain	1999	240
Driving ability in cancer patients receiving long-term morphine analgesia Anneli Vainio, Per H. Rosenberg, Eija Kalso, The Lancet OncologyAddictionPain MedicinePostoperative Pain ManagementCancer Pain	1995	222
Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain. Eduardo Bruera, Mathieu Belzile, Edith Pituskin, Journal of Clinical Oncology	1998	203
The bioavailability and pharmacokinetics of morphine after intravenous, oral and buccal administration in healthy volunteers. GW Hanks, G. Wynne Aherne, Daniel P. Chapman, British Journal of Clinical Pharmacology	1989	169
Pain treatment and outcomes for patients with advanced cancer who receive follow-up care at home Sebastiano Mercadante Cancer	1999	149

Page 1